Managing Skin Diseases that Flare During Pregnancy and in the Postpartum period: Part 1-Classification, Epidemiology & Pathogenesis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 41707708.
- Also identified by DOI 10.1016/j.jaad.2026.01.089.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pregnancy induces immunologic, hormonal, vascular, neurogenic and skin barrier changes that may exacerbate inflammatory dermatoses as atopic dermatitis (AD), and psoriasis. Part I of this CME reviews pregnancy-induced shifts in immunity, hormones, vascular dynamics and barrier function that can change the course of common dermatoses, including AD, psoriasis, acne, melasma, hidradenitisi suppurativa, and other conditions. Additionally, in Part II we present updated safety and pharmacokinetic data that supports the judicious use of topical, systemic and procedural therapies (eg, phototherapy, biologics) through gestation and lactation, replacing reliance solely on FDA categories. We include practical treatment options to enhance the balancing of maternal disease control with fetal and neonatal safety.